Literature DB >> 1394847

Enhanced hprt mutant frequency but no significant difference in mutation spectrum between a smoking and a non-smoking human population.

H Vrieling1, J C Thijssen, A M Rossi, F J van Dam, A T Natarajan, A D Tates, A A van Zeeland.   

Abstract

Recently, we have observed a small (36%), but significant, enhancement of the frequency of 6-thioguanine (6-TG)-resistant T-lymphocytes in blood from smokers. The molecular nature of 43 hypoxanthine-guanine phosphoribosyltransferase (hprt) mutant T-lymphocyte clones from nine smoking individuals was determined to investigate whether the increase in hprt mutant frequency would lead to a changed mutation spectrum. The types and distribution of hprt mutations in smokers was compared with those found in 55 6-TGr T-lymphocyte clones from 12 members of a control group of non-smokers. From this control group 25 hprt mutants were novel, whereas 31 have been described previously. Among smokers and non-smokers, a similar proportion of base substitutions (approximately 35%), mutations causing aberrant splicing (approximately 37%), frameshifts (approximately 16%) and deletions (approximately 9%) was found. In both groups, GC----AT base pair changes were found to be predominant among transitions. However, whereas all types of transversions were about equally represented in non-smokers, GC----TA transversions were not recovered among smokers. Investigation of the distribution of base substitutions over the hprt coding region showed no differences between the two groups. These data provide no clues on the nature of DNA adducts induced by smoking, which are thought to be responsible for the increased mutation frequency at the hprt locus in T-lymphocytes from smokers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1394847     DOI: 10.1093/carcin/13.9.1625

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  4 in total

1.  Influence of sex, smoking and age on human hprt mutation frequencies and spectra.

Authors:  J Curry; L Karnaoukhova; G C Guenette; B W Glickman
Journal:  Genetics       Date:  1999-07       Impact factor: 4.562

2.  Identification of genomic mutations associated with clinical outcomes of induction chemotherapy in patients with head and neck squamous cell carcinoma.

Authors:  Chan-Young Ock; Bongjun Son; Bhumsuk Keam; Seung-Youn Lee; Jaewoo Moon; Hwanjong Kwak; Sehui Kim; Tae Min Kim; Yoon Kyung Jeon; Seong Keun Kwon; J Hun Hah; Se-Hoon Lee; Tack-Kyun Kwon; Dong-Wan Kim; Hong-Gyun Wu; Myung-Whun Sung; Dae Seog Heo
Journal:  J Cancer Res Clin Oncol       Date:  2015-12-16       Impact factor: 4.553

3.  Characterization of in vivo somatic mutations at the hypoxanthine phosphoribosyltransferase gene of a human control population.

Authors:  K Burkhart-Schultz; C B Thomas; C L Thompson; C L Strout; E Brinson; I M Jones
Journal:  Environ Health Perspect       Date:  1993-04-22       Impact factor: 9.031

4.  Mechanisms for induction of mutations and chromosome alterations.

Authors:  A T Natarajan
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.